Body Composition

Effects of 5:2 intermittent fasting meal replacement on body composition and abdominal fat distribution in overweight and obese adults with early type 2 diabetes.

TL;DR

The 5:2 intermittent fasting meal replacement regimen may be more effective than metformin and empagliflozin in improving body composition and abdominal fat distribution in early T2DM, and is proposed as a therapeutic option.

Key Findings

The 5:2 MR group showed significantly greater reductions in BMI compared with metformin and empagliflozin groups.

  • Least-squares mean BMI reduction was -3.41 kg/m2 (SE 0.31), P < 0.001
  • Single-center analysis of a randomized, active-controlled trial (EARLY) with 85 total participants
  • 5:2 MR group n=29, metformin group n=28, empagliflozin group n=28
  • Treatment duration was 16 weeks
  • Participants were overweight and obese patients with early T2DM

The 5:2 MR group demonstrated significantly greater reductions in multiple abdominal obesity indices compared to the medication groups.

  • Waist circumference reduction: -8.83 cm (SE 1.07), P < 0.001
  • Waist-to-hip ratio (WHR) reduction: -0.04 (SE 0.01), P < 0.05
  • Waist-to-height ratio (WHtR) reduction: -0.05 (SE 0.01), P < 0.001
  • All comparisons were versus both metformin and empagliflozin groups

The 5:2 MR group showed significantly greater reductions in body fat percentage and abdominal fat areas compared to the other groups.

  • Body fat percentage (BF%) reduction: -4.84% (SE 0.66), P < 0.05
  • Abdominal cross-sectional area (ACSA) reduction: -66.05 cm2 (SE 9.46), P < 0.01
  • Subcutaneous fat area reduction: -58.27 cm2 (SE 5.99), P < 0.001
  • Body composition was assessed using InBody device; abdominal fat distribution was measured using energy spectrum CT

The 5:2 MR group showed a significantly greater increase in the liver-to-spleen (L/S) ratio compared to the medication groups, suggesting reduction in hepatic fat.

  • L/S ratio increase: 0.43 (SE 0.04), P < 0.01
  • L/S ratio was measured using energy spectrum CT
  • This finding indicates improvement in hepatic steatosis in the 5:2 MR group

In the 5:2 MR group, changes in BMI were positively correlated with changes in multiple body composition and abdominal fat measures.

  • BMI change correlated with WHR change: r = 0.411, P = 0.030
  • BMI change correlated with WHtR change: r = 0.635, P < 0.001
  • BMI change correlated with BF% change: r = 0.528, P = 0.020
  • BMI change correlated with ACSA change: r = 0.562, P = 0.003
  • Associations were evaluated using Spearman's correlation coefficient and described as linear associations

Have a question about this study?

Citation

Yu D, Zou M, Cheng B, Yang P, Huang D, Pan Q, et al.. (2026). Effects of 5:2 intermittent fasting meal replacement on body composition and abdominal fat distribution in overweight and obese adults with early type 2 diabetes.. Clinical nutrition (Edinburgh, Scotland). https://doi.org/10.1016/j.clnu.2025.11.025